Parathyroid carcinoma survival: improvements in the era of intact parathyroid hormone monitoring?
The intact parathyroid hormone (iPTH) assay is a critical test in the diagnosis and management of PTH-mediated hypercalcemia, including parathyroid carcinoma (PCa). We hypothesized that the survival of patients diagnosed with PCa has improved since adoption of the iPTH assay into clinical practice....
Egile Nagusiak: | , , , |
---|---|
Formatua: | Artikulua |
Hizkuntza: | English |
Argitaratua: |
SAGE Publishing
2013-02-01
|
Saila: | Rare Tumors |
Gaiak: | |
Sarrera elektronikoa: | http://www.pagepress.org/journals/index.php/rt/article/view/4477 |